FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-5124fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5124fjev1
20/10/1724    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercado, M. L.
Right arrow Articles by Fallon, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercado, M. L.
Right arrow Articles by Fallon, J. R.
(The FASEB Journal. 2006;20:1724-1726.)
© 2006 FASEB

Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS

Mary Lynn Mercado*, Alison R. Amenta*, Hiroki Hagiwara*, Michael S. Rafii*, Beatrice E. Lechner*, Rick T. Owens{dagger}, David J. McQuillan{dagger}, Stanley C. Froehner{ddagger} and Justin R. Fallon*,1

* Department of Neuroscience, Brown University, Providence, Rhode Island, USA;

{dagger} LifeCell Corporation, Branchburg, New Jersey, USA; and

{ddagger} Department of Physiology and Biophysics, University of Washington, Seattle, Washington, USA

1Correspondence: Department of Neuroscience, Brown University, 190 Thayer St., Box 1953, Providence, RI 02912 USA. E-mail: Justin_Fallon{at}brown.edu

ABSTRACT

The dystrophin-associated protein complex (DAPC) provides a linkage between the cytoskeleton and the extracellular matrix (ECM) and is also a scaffold for a host of signaling molecules. The constituents of the DAPC must be targeted to the sarcolemma in order to properly function. Biglycan is an ECM molecule that associates with the DAPC. Here, we show that biglycan null mice exhibit a mild dystrophic phenotype and display a selective reduction in the localization of {alpha}-dystrobrevin-1 and -2, {alpha}- and ß1-syntrophin, and nNOS at the sarcolemma. Purified biglycan induces nNOS redistribution to the plasma membrane in cultured muscle cells. Biglycan protein injected into muscle becomes stably associated with the sarcolemma and ECM for at least 2 wk. This injected biglycan restores the sarcolemmal expression of {alpha}-dystrobrevin-1 and -2, and ß1- and ß2-syntrophin in biglycan null mice. We conclude that biglycan is important for the maintenance of muscle cell integrity and plays a direct role in regulating the expression and sarcolemmal localization of the intracellular signaling proteins dystrobrevin-1 and -2, {alpha}- and ß1-syntrophin and nNOS.—Mercado, M. L., Amenta, A. R., Hagiwara, H., Rafii, M. S., Lechner, B., Owens, R. T., McQuillan, D. J., Froehner, S. C., Fallon, J. R. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.